| Joseph Paul Padayhag, MD | |
|
215 Toll Gate Rd, Suite 301, Warwick, RI 02886-4458 | |
| (401) 738-5500 | |
| Not Available |
| Full Name | Joseph Paul Padayhag |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 215 Toll Gate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033317524 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4444 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Paul Padayhag, MD 215 Toll Gate Rd, Suite 301, Warwick, RI 02886-4462 Ph: (401) 738-5500 | Joseph Paul Padayhag, MD 215 Toll Gate Rd, Suite 301, Warwick, RI 02886-4458 Ph: (401) 738-5500 |
News Archive
Treatment of psychosis can be targeted to a specific genetic mutation in patients with psychotic disorders, according to a study in Biological Psychiatry, published by Elsevier.
Giuseppe Verlato, an epidemiologist at the University of Verona, asked participants to recall whether they smoked between the ages of 11 and 20 and if they had suffered from asthma as young children.
Despite a sluggish year, health care investors can look forward to growing emerging markets and a possible change in the U.S. political climate, Forbes reports. "Health care has not had a banner year in 2010 as the sector's stocks have underperformed the market on account of reform in the United States and financial problems in Europe. But there's hope for investors in shares of companies that stand on their own fundamentals, particularly those that have been successful in growing sales to emerging markets.
Replacing one amino acid on the surface of a virus that shepherds corrective genes into cells could be the breakthrough scientists have needed to make gene therapy a more viable option for treating genetic diseases such as hemophilia, University of Florida researchers say.
The House Energy and Commerce Committee is scheduled to hold a hearing on Wednesday, January 8, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.
› Verified 9 days ago
Dr. Sterling Leaf Malish, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 | |
Dr. Jennifer F Jarbeau, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Bald Hill Rd Ste 524, Warwick, RI 02886 Phone: 401-737-7313 Fax: 401-737-4207 |